openPR Logo
Press release

Immuno-oncology Drugs Market Growth in Future Scope 2024-2031 | AbbVie Inc., AstraZeneca, Bristol-Myers Squibb Company, Dendreon Pharmaceuticals LLC

06-26-2024 11:33 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Immuno-oncology Drugs Market

Immuno-oncology Drugs Market

Immuno-oncology Drugs Market Report 2024 -2031 studies the many aspects of the industry like the market size, market status, market trends, and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Immuno-oncology Drugs Market analysis segmented by companies, region, type, and applications in the report.

Scope of Market report evaluates the growth rate and the market value based on market dynamics, growth inducing factors. The complete knowledge is based on the latest industry news, opportunities, and trends. The report contains a comprehensive market analysis and vendor landscape in addition to a SWOT analysis of the key vendors.

Request a Sample Copy with More Details: - https://www.coherentmarketinsights.com/insight/request-sample/1271

** Note - This report sample includes:

Market size from 2024 to 2031

Table of Contents (Scope covered as a part of the study)

Top players in the market

Research framework (structure of the report)

Research methodology adopted by Coherent Market Insights

Major companies in Market are:

◘ AbbVie Inc.
◘ AstraZeneca
◘ Bristol-Myers Squibb Company
◘ Dendreon Pharmaceuticals LLC.
◘ F. Hoffmann-La Roche Ltd.
◘ Merck & Co. Inc.
◘ Novartis AG
◘ Pfizer Inc.
◘ Sanofi
◘ Ferring B.V.
◘ Enzo Biochem Inc.
◘ Celldex Therapeutics
◘ Atara Biotherapeutics Inc.
◘ Apexigen
◘ BioNTech SE
◘ Blueprint Medicines Corporation
◘ Regeneron Pharmaceuticals Inc.
◘ CytomX Therapeutics Inc.
◘ Agenus Inc.
◘ Betta Pharmaceuticals Co., Ltd.,
◘ CStone Pharmaceuticals
◘ Amgen Inc.
◘ MediMergent LLC
◘ Gilead Sciences Inc.
◘ ONKO-INNATE

By Treatment Type: Immune Checkpoint Inhibitors ( PD-1, PD-L1, CTLA-4), Immune System Modulators, Cancer Vaccines, Oncolytic Virus, Others
By Disease Type: Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Prostate Cancer, Bladder Cancer, Others (Breast Cancer, Thyroid Cancer, etc.)
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

→ In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges, and risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

→ The complete research assessment of the Global Immuno-oncology Drugs Market provides a granular analysis of the industry's new upgrades, censorious trends, current market pilots, challenges, and standardization and technical domain.

Purchase this Complete Market Report and Get (Up to 25% OFF) at: https://www.coherentmarketinsights.com/insight/buy-now/1271

This report also splits the market by region:

◘ North America (United States, Canada, and Mexico)
◘ Europe (Germany, France, UK, Russia, Italy)
◘ Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
◘ South America (Brazil, Argentina, Colombia)
◘ Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Global Immuno-oncology Drugs Market 2024 Key Insights:

- Research and analyze the Immuno-oncology Drugs Market standing and future forecast associated with production, Immuno-oncology Drugs price structure, consumption, and Immuno-oncology Drugs Market historical knowledge.

- The report understands the structure of Immuno-oncology Drugs trade by distinguishing its varied segments and sub-segments.

- Market split the breakdown knowledge by company, products, end-user, and prime countries, Immuno-oncology Drugs Market history knowledge from 2016 to 2023 and forecast to 2031.

- Analysis of Immuno-oncology Drugs Market regarding individual growth trends, future prospects, and their contribution to the overall Immuno-oncology Drugs Market.

- Global Immuno-oncology Drugs Market 2024 report analyzes competitive expansions like agreements, new product launches, and Immuno-oncology Drugs Market acquisitions.

- Research report target the key international Immuno-oncology Drugs players to characterize sales volume, Immuno-oncology Drugs revenue, growth potential, drivers, SWOT analysis, and Immuno-oncology Drugs development plans in the coming years.

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/1271

Highlights of the Global Immuno-oncology Drugs report:

‣ A complete backdrop analysis, which includes an assessment of the Immuno-oncology Drugs Market

‣ An objective assessment of the trajectory of the market

‣ Market segmentation up to the second or third level

‣ Reporting and evaluation of recent industry developments

‣ Important changes in market dynamics

‣ Emerging niche segments and regional markets

‣ Historical, current, and projected size of the market from the standpoint of both value and volume

‣ Market shares and strategies of key players

‣ Recommendations to companies for strengthening their foothold in the market

The report has been collated on the basis of synthesis, analysis, and interpretation of data accumulated with regard to the parent market from various resources. Additionally, study has been made of the economic conditions and other economic indicators and factors to evaluate their respective impact on the Immuno-oncology Drugs Market, along with the present impact, so as to make strategic and informed forecasts about the scenarios in the market. This is primarily because of the untapped potential present in the developing nations, in terms of product pricing and revenue generation.

About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
Australia:+61-2-4786-0457
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immuno-oncology Drugs Market Growth in Future Scope 2024-2031 | AbbVie Inc., AstraZeneca, Bristol-Myers Squibb Company, Dendreon Pharmaceuticals LLC here

News-ID: 3554263 • Views:

More Releases from Coherent Market Insights

Current Sensor Market Set to Witness Significant Growth by 2025-2032 - Coherent Market Insights
Current Sensor Market Set to Witness Significant Growth by 2025-2032 - Coherent …
The Current Sensor market is estimated to be valued at USD 3.42 Bn in 2025 and is expected to reach USD 6.75 Bn by 2032, growing at a compound annual growth rate CAGR of 10.2% from 2025 to 2032. ➤ Coherent Market Insights has published an in-depth research report titled "Current Sensor Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This study offers a deep dive into the Current
U.S. Bodyguard Service & Security Consulting Market Evolution by 2032 - Disruptive Innovations, Regional Insights, and Growth Opportunities
U.S. Bodyguard Service & Security Consulting Market Evolution by 2032 - Disrupti …
The U.S. Bodyguard Service & Security Consulting market is estimated to be valued at USD 2.57 Bn in 2025 and is expected to reach USD 3.52 Bn by 2032, growing at a compound annual growth rate CAGR of 4.6% from 2025 to 2032. ➤ Coherent Market Insights has published an in-depth research report titled "U.S. Bodyguard Service & Security Consulting Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This
Single Cell Sequencing Market Set for Dynamic Boom as Key Players Illumina, BD Biosciences, Pacific Biosciences, Thermo Fisher Scientific
Single Cell Sequencing Market Set for Dynamic Boom as Key Players Illumina, BD B …
The qualitative latest Research report (2025-2032) on the Single Cell Sequencing Market 2025 - 2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. ➤ Request a Sample
Nuclear Medicine Equipment Market Set for Demonstrate Strong Growth During 2025-2032 with Key Players GE Healthcare, Siemens Healthineers, Philips, and Canon Medical Systems
Nuclear Medicine Equipment Market Set for Demonstrate Strong Growth During 2025- …
The qualitative latest Research report (2025-2032) on the Nuclear Medicine Equipment Market 2025 - 2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. ➤ Request a Sample

All 5 Releases


More Releases for Drugs

Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$